Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Aardvark Therapeutics, Inc. has filed 99 SEC EDGAR filings since 24 May 2019

SEC filing history

Showing 76-99 of 99 matching filings.

Per page
25
Current page
4
3

3

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-42513

CERT filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-42513

8-A12B

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-284440

S-1/A

Filing date
06 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-284440

S-1

Filing date
23 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-07518

DRS/A filing

Filing date
23 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
20 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 377-07518

UPLOAD filing

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
27 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS/A File 377-07518

DRS/A filing

Filing date
27 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 377-07518

UPLOAD filing

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-07518

DRS filing

Filing date
24 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-513397

D filing

Filing date
15 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-402004

D filing

Filing date
07 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-340343

D filing

Filing date
24 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .